Revisiting Jumia’s JForce scandal and Citron's short-sell claims

Revisiting Jumia’s JForce scandal and Citron's short-sell claimsIn advance of Jumia's November financial reporting, it's worth revisiting the company's second quarter results, the downside of which included some negative news beyond losses. What appears to have struck the market more than revenues or losses was Jumia offering greater detail on the fraud perpetrated by some employees and agents of its JForce sales program. At quick glance, Citron's primary claim — that Jumia's SEC filing contained discrepancies in sales figures — shares some resemblance to Jumia's own disclosures.




from Yahoo Tech https://ift.tt/31ROMBt

Comments

Post a Comment

Popular posts from this blog

Johnson & Johnson partners with BARDA to fund $1 billion in COVID-19 vaccine research

Image
Pharmaceutical giant Johnson & Johnson is partnering with the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services to fund over $1 billion in COVID-19 vaccine and antiviral treatment research and development, the company said on Monday. The partnership is an expansion of an existing agreement between BARDA and J&J's Janssen Pharmaceutical Companies division. With the agreement, the company is setting a goal of providing a global supply of more than one billion doses of the vaccine, which J&J expects to have in clinical trials by September 2020 at the latest. from Yahoo Tech https://ift.tt/2JDqGEd
Read more

Deliveroo cuts ~15% of staff as coronavirus challenges food delivery

Image
Is it feast or famine for food delivery startups during the coronavirus pandemic? The UK's Deliveroo has confirmed it's axing more than 350 staff -- or around 15% of its global headcount. A Deliveroo spokesman blamed the cuts on the coronavirus crisis, saying the public health emergency has put pressure on the business to reduce long-term costs. from Yahoo Tech https://ift.tt/3cT72QQ
Read more